PT Prodia Widyahusada TbkPRWDF 76 Return-on-Tangible-Equity is 3.19% as of Mar. 2026, which is 75% below its 10-year median of 12.62. GuruFocus rates PRWDF with a GF Scoreâ„¢ of 76/100. The stock has 2 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks better than 67.53% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. PT Prodia Widyahusada Tbk's annualized net income for the quarter that ended in Mar. 2026 was $4.07 Mil. PT Prodia Widyahusada Tbk's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $127.76 Mil. Therefore, PT Prodia Widyahusada Tbk's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 3.19%.
The historical rank and industry rank for PT Prodia Widyahusada Tbk's Return-on-Tangible-Equity or its related term are showing as below:
PRWDF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 9.56 Med: 12.62 Max: 30.74
Current: 10.24
During the past 13 years, PT Prodia Widyahusada Tbk's highest Return-on-Tangible-Equity was 30.74%. The lowest was 9.56%. And the median was 12.62%.
PRWDF's Return-on-Tangible-Equity is ranked better than 67.53% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.185
vs PRWDF: 10.24
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
PT Prodia Widyahusada Tbk Return-on-Tangible-Equity Related Terms
PT Prodia Widyahusada Tbk Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for PT Prodia Widyahusada Tbk's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRWDF vs TMO, DHR, IDXX: Return-on-Tangible-Equity Comparison
For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Prodia Widyahusada Tbk Return-on-Tangible-Equity vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where PT Prodia Widyahusada Tbk's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 3.19% mean?
PT Prodia Widyahusada Tbk (PRWDF) has a Return-on-Tangible-Equity of 3.19% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Prodia Widyahusada Tbk and its competitors. This is 75% below median its historical median of 12.62. Over the past decade, PT Prodia Widyahusada Tbk's Return-on-Tangible-Equity has ranged from 9.56 to 30.74. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #63 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 32.5%.
Is PT Prodia Widyahusada Tbk's Return-on-Tangible-Equity too high?
PT Prodia Widyahusada Tbk's current Return-on-Tangible-Equity of 3.19% is 75% below median its 10-year median of 12.62. Over the past 10 years, this metric has ranged from a low of 9.56 to a high of 30.74. The Medical Diagnostics & Research industry median Return-on-Tangible-Equity is 0.19. PT Prodia Widyahusada Tbk's value of 3.19% is 1624.3% above this industry median. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #63 out of 194 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, PT Prodia Widyahusada Tbk has a GF Scoreâ„¢ of 76/100, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's Return-on-Tangible-Equity compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #63 out of 194 companies for Return-on-Tangible-Equity. This puts PT Prodia Widyahusada Tbk in the upper half of its industry. The industry median Return-on-Tangible-Equity is 0.19. PT Prodia Widyahusada Tbk's value of 3.19% is 1624.3% above this benchmark. Historically, PT Prodia Widyahusada Tbk's own Return-on-Tangible-Equity has ranged from 9.56 to 30.74 over the past decade. While the company's 10-year median is 12.62 vs. the industry median of 0.19, PT Prodia Widyahusada Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Diagnostics & Research company?
The median Return-on-Tangible-Equity among Medical Diagnostics & Research companies is 0.19, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Prodia Widyahusada Tbk's current Return-on-Tangible-Equity of 3.19% is 1624.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Prodia Widyahusada Tbk and its competitors. For the Medical Diagnostics & Research industry, the median Return-on-Tangible-Equity is 0.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current Return-on-Tangible-Equity is 3.19%, which is 75% below median its own 10-year median of 12.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
PT Prodia Widyahusada Tbk (PRWDF) has a current Return-on-Tangible-Equity of 3.19%. The current Return-on-Tangible-Equity is 3.19%, which is 75% below median its 10-year median of 12.62 and 1624.3% above the Medical Diagnostics & Research industry median of 0.19. PT Prodia Widyahusada Tbk's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (PRWDF), the current Return-on-Tangible-Equity is 3.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRWDF has been successfully added to your 